Quality of life in neuro-Behçet’s disease: a cross-sectional study

Abstract

Purpose

Behçet’s disease (BD) is a multisystemic perivasculitis with recurrent oral aphthous ulcers, genital ulcers, and eye involvement which was first described in 1937. Neurological involvement in BD patients is referred to as neuro-Behçet’s disease (NBD). Studies have shown that BD worsens quality of life. However, there is no study that conducts a head-to-head comparison of quality of life between NBD patients and healthy controls.

Methods

Forty patients with NBD and 39 age-sex-matched healthy control subjects were included in this study. Sociodemographic data of all participants were recorded; SF-36 was used to assess quality of life.

Results

NBD patients had significantly lower SF-36 scores of physical functioning, physical difficulty, bodily pain, and general health perception compared with healthy controls. However, there was no significant difference between the groups according to the SF-36 scores of role limitation due to emotional problems, mental health, vitality, and social functioning. There was no significant difference between parenchymal and non-parenchymal NBD groups according to SF-36, Beck’s Depression Inventory, and Beck’s Anxiety Inventory scores. Patients with cerebellar system involvement had significantly lower physical and social functioning scores compared with those who did not. Patients with brain stem involvement were found to have higher role limitation due to emotional problems, vitality, social functioning, physical pain, and general health perception scores compared with those without brain stem findings.

Conclusions

NBD negatively affects many aspects of the quality of life.

This is a preview of subscription content, log in to check access.

Data availability

All data generated or analyzed during this study are included in this published article (and its supplementary information files).

References

  1. 1.

    Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291

    Article  CAS  Google Scholar 

  2. 2.

    Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54(3):213–220

    Article  CAS  Google Scholar 

  3. 3.

    Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulku BY, Muftuoglu AU (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Ann Rheum Dis 43(6):783–789

    Article  CAS  Google Scholar 

  4. 4.

    Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Ha A, Constantinescu CS, Houman H, Mahr A, Salvarani C, Sfikakis PP, Siva A, Al-Araji A (2014) Diagnosis and management of neuro-Behcet’s disease: international consensus recommendations. J Neurol 261(9):1662–1676

    Article  Google Scholar 

  5. 5.

    Aykac SC, Gökcay F, Calli C (2019) What is the role of diffusion tensor imaging (DTI) in detecting subclinical pyramidal tract dysfunction in Behçet’s and neuro-Behçet’s cases? Neurological Sciences 40(4):753–758

    Article  Google Scholar 

  6. 6.

    Al-Araji A, Kidd DP (2009) Neuro-Behcet’s disease: epidemiology, clinical characteristics, and management. Lancet Neuro 18(2):192–204

    Article  Google Scholar 

  7. 7.

    Uygunoğlu U, Siva A (2018) Behçet’s syndrome and nervous system involvement. Current neurology and neuroscience reports 18(7):35

    Article  Google Scholar 

  8. 8.

    Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlai M, Faezi T, Odsi Z, ABHollahi BS, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M (2017) Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol 13(1):57–65

  9. 9.

    Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behcet’s syndrome. Brain 122(Pt 11):2183–2194

    Article  Google Scholar 

  10. 10.

    Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122(Pt 11):2171–2182

    Article  Google Scholar 

  11. 11.

    Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behcet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248(2):95–103 (2006)

    Article  CAS  Google Scholar 

  12. 12.

    Bodur H, Borman P, Ozdemir Y, Atan C, Kural G (2006) Quality of life and life satisfaction in patients with Behcet’s disease: relationship with disease activity. Clin Rheumatol 25(3):329–333

    Article  Google Scholar 

  13. 13.

    Bernabe E, Marcenes W, Mather J, Phillips C, Fortune F (2010) Impact of Behcet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford) 49(11):2165–2171

    Article  Google Scholar 

  14. 14.

    Canpolat O, Yurtsever S (2011) The quality of life in patients with Behcet’s disease. Asian Nurs Res (Korean Soc Nurs Sci) 5(4):229–235

    Google Scholar 

  15. 15.

    (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080

  16. 16.

    Vladetić M, Jančuljak D, Soldo SB, Kralik K, Buljan K (2017) Health-related quality of life and ways of coping with stress in patients with migraine. Neurol Sci 38(2):295–301

    Article  Google Scholar 

  17. 17.

    Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H (1999 Aug) Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome. Rheumatology (Oxford). 38(8):734–736

    Article  CAS  Google Scholar 

  18. 18.

    Koçyiğit HA, Ö, Ölmez N, Memiş A (1999) SF-36’ nın Türkçe için güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi 12:102–106

    Google Scholar 

  19. 19.

    Fabiani C, Vitale A, Orlando I, Sota J, Capozzoli M, Franceschini R, Galeazzi M, Tosi GM, Frediani B, Cantarini L (2017) Quality of life impairment in Behcet’s disease and relationship with disease activity: a prospective study. Emerg Med Intern. 12(7):947–955

    Article  Google Scholar 

Download references

Code availability

Not applicable.

Funding

The research was supported by ourselves.

Author information

Affiliations

Authors

Contributions

BB and MKK analyzed and interpreted the patients’ data .MKK collected the data and was a major contributor in planning and writing the manuscript. CY contributed to the planning and manuscript writing of the study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Müge Kuzu Kumcu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study conforms to the principles outlined in the Declaration of Helsinki. Ankara University School of Medicine clinical research ethics committee has approved the study protocols at July 27, 2015 (registrations number: 12.507.05).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(SAV 6 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kuzu Kumcu, M., Bakırarar, B. & Yücesan, C. Quality of life in neuro-Behçet’s disease: a cross-sectional study. Neurol Sci (2020). https://doi.org/10.1007/s10072-020-04630-z

Download citation

Keywords

  • Quality of life
  • SF-36
  • Neuro-Behçet’s disease